SSC Bidders Get More Time

WASHINGTON—States competing for the Superconducting Supercollider have been given 30 more days to submit their proposals to the Department of Energy. The department’s original deadline of August 3 for proposals, announced last winter, produced howls of outrage from states that had waited to mount their campaigns until President Reagan threw his support behind the multibillion-dollar project. They complained they could never catch up to the handful of states that had already spent

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WASHINGTON—States competing for the Superconducting Supercollider have been given 30 more days to submit their proposals to the Department of Energy.

The department’s original deadline of August 3 for proposals, announced last winter, produced howls of outrage from states that had waited to mount their campaigns until President Reagan threw his support behind the multibillion-dollar project. They complained they could never catch up to the handful of states that had already spent millions of dollars developing their proposals, and bidded for a later deadline.

An amendment to an otherwise unrelated money bill, voted July 1 by Congress, gave DOE officials an excuse to push the deadline back to September 2. The amendment deletes as a consideration in the review process a provision that states can tempt the government with financial incentives.

The official reason for the delay is “to provide potential proposers adequate time to make changes to comply with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies